EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Denosumab Regulates Titanium Particles‐Induced Macrophages Inflammation and Osteolysis by Targeting the ST18 / PARP1 Interaction

Zhipeng Chen iD, Fan Yang, Yifan Yu, Junxi Chen, Jichao Ye, Yue Ding

Orthopaedic Surgery · 2026

DOI: 10.1111/os.70211 ↗

At a glance

Journal article in Orthopaedic Surgery, 2026. Written by Zhipeng Chen and 5 co-authors. Institution: Department of Orthopedic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. Major MEDLINE topics: Osteolysis, Titanium, Macrophages, Inflammation. 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Research Fund for Innovative Ideas in Osteoporosis, Medical Science and Technology Research Foundation of Guangdong Province, Yat-sen Qihang Foundation of Sun Yat-sen Memorial Hospital.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

This study aims to investigate the role of Denosumab and its downstream target ST18 in wear particle‐induced macrophage inflammation and osteolysis, and to explore the underlying mechanisms involved in aseptic loosening (AL) of prosthetic joints.

Methods

Macrophages were stimulated with titanium particles (TiPs), and inflammatory responses were assessed using qRT‐PCR, western blot, flow cytometry, and immunohistochemistry. Denosumab's effects on inflammation and osteolysis were evaluated with the same approaches. Potential targets of Denosumab were screened via online databases and validated by qRT‐PCR and western blot. ST18 was modulated in macrophages using lentiviral overexpression and knockdown systems. A mouse calvarial model of TiPs‐induced osteolysis was established, and the roles of Denosumab and ST18 were examined in vivo using micro‐CT, H&E staining, and tartrate‐resistant acid phosphatase (TRACP) staining.

Results

Denosumab suppressed TiPs‐induced macrophage inflammation by inhibiting NF‐κB signaling and M1 polarization. We identified ST18 as a direct target of Denosumab, whose expression was upregulated by TiPs but downregulated by Denosumab. Lentivirus‐mediated ST18 knockdown markedly attenuated TiPs‐induced inflammation, whereas ST18 overexpression exacerbated it. Further analysis revealed that ST18 interacts with PARP1. In vivo, Denosumab significantly alleviated TiPs‐induced osteolysis in mouse calvaria, an effect that was reversed by ST18 overexpression.

Conclusion

Denosumab attenuates TiPs‐induced macrophage activation and osteolysis through suppression of the NF‐κB pathway and M1 polarization, with ST18 serving as a key mediator. These findings highlight Denosumab as a promising therapeutic candidate for the prevention of prosthesis‐related aseptic loosening.

Subjects

MeSH terms (MEDLINE)

OsteolysisTitaniumMacrophagesInflammationDenosumabPoly (ADP-Ribose) Polymerase-1Bone Density Conservation AgentsAnimalsMiceProsthesis FailureMice, Inbred C57BLDisease Models, Animal

Author keywords

DenosumabST18aseptic looseningmacrophage inflammationosteolysis

Substances

TitaniumDenosumabPoly (ADP-Ribose) Polymerase-1Bone Density Conservation Agents

Authors and institutions

  • Department of Orthopedic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

ORCID profiles: Zhipeng Chen

Funding

  • Research Fund for Innovative Ideas in Osteoporosis
  • Medical Science and Technology Research Foundation of Guangdong Province
  • Yat-sen Qihang Foundation of Sun Yat-sen Memorial Hospital
  • Guangdong Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province

Cite

APA

Chen, Z., Yang, F., Yu, Y., Chen, J., Ye, J., & Ding, Y. (2026). Denosumab Regulates Titanium Particles‐Induced Macrophages Inflammation and Osteolysis by Targeting the ST18 / PARP1 Interaction. Orthopaedic Surgery. https://doi.org/10.1111/os.70211

Vancouver

Chen Z, Yang F, Yu Y, Chen J, Ye J, Ding Y. Denosumab Regulates Titanium Particles‐Induced Macrophages Inflammation and Osteolysis by Targeting the ST18 / PARP1 Interaction. Orthopaedic Surgery. 2026. doi:10.1111/os.70211

BibTeX
@article{Chen2026,
  author = {Chen, Zhipeng and Yang, Fan and Yu, Yifan and Chen, Junxi and Ye, Jichao and Ding, Yue},
  title = {Denosumab Regulates Titanium Particles‐Induced Macrophages Inflammation and Osteolysis by Targeting the ST18 / PARP1 Interaction},
  journal = {Orthopaedic Surgery},
  year = {2026},
  doi = {10.1111/os.70211}
}
Start for free →